Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Methotrexate

EU orphan designation number: EU/3/16/1723   
Active ingredient: Methotrexate
Indication: Treatment of alkaptonuria
Sponsor: aimAKU (Associazione Italiana Malati di Alcaptonuria)
Piazza S. Spirito 1, 53100 Siena, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/086/16 (2016)5630 of 29/08/2016